Kytril® (also Kevatril®)

For the prevention and treatment of acute nausea and vomiting associated with chemotherapy and radiotherapy.

Formulations: Film-coated 1mg and 2mg tablets • 1mg/1ml and 3mg/3ml ampoules
Territories: Approximately 80 territories globally (excluding Japan and US)

Please note

Whilst the Patient Information Leaflets (PIL) and Summary of Product Characteristics (SmPC) product information is intended to be helpful, we stress that this is not intended to, and should not, replace the advice of a qualified medical professional.

If you experience any side effects that cause you concern as a result of the use of any of our products and wish to notify us directly please get in touch via our contact page.


Please note that the above links are relevant to UK marketing authorisation requirements only. Patients and carers in the Republic of Ireland can find similar information at however, if you are from outside the UK, your local country requirements may differ. Please refer to your local country PIL or SPC, if you are a patient or HCP respectively, for further guidance.

Where we have included Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) downloads, we have used the English language versions for the UK (unless otherwise stated). If you would like other language versions for other markets, please contact

Back to all products